Narious aspects of non-thyroidal illness;'Non-thyroidal illness' oder syndrom veranderter schilddrusenhormonparameter bei patienten mit nichtthyreoidalen erkrankungen

Medizinische Klinik

Volumn 93, Issue 11, 1998, Pages 662-668

  Reinhardt, Walter ^a   Mann, Klaus ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Low T3; Non thyroidal illness; Sick euthyroid syndrome; Syndrome; Thyroidfunction

Indexed keywords

3,3',5' TRIIODOTHYRONINE; LIOTHYRONINE; THYROGLOBULIN; THYROID ANTIBODY; THYROXINE; THYROXINE DEIODINASE; THYROID HORMONE;

ECHOGRAPHY; EUTHYROIDISM; HUMAN; REVIEW; SYNDROME; THYROID DISEASE; THYROID SCINTISCANNING; BLOOD; DIFFERENTIAL DIAGNOSIS; EUTHYROID SICK SYNDROME; THYROID FUNCTION TEST;

DIAGNOSIS, DIFFERENTIAL; EUTHYROID SICK SYNDROMES; HUMANS; THYROID FUNCTION TESTS; THYROID HORMONES;

EID: 0031763535     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03044878     Document Type: Review

References (83)

1. Bayer MF. Free thyroxine results are affected by albumin concentrations and non thyroidal illness. Clin Chim Acta 1983;130:391-6
2. Becker RA, Vaughan GM, Ziegler MG, et al. Hypermetabolic low triiodothyronine syndrome of burn injury. Crit Care Med 1982;10:870-6.
3. Besses GS, Burrow GN, Spaulding SW, et al Dopamine infusion acutely inhibits the TSH and prolactin response co TRH. J Clin Endocrinol Metab 1975;41:985-90.
4. Blacksheai JL, Schultz AL, NapierJS, et al. Thyroxine replacement requirements in hypothyroid patients receiving phenytoin. Ann Intern Med 1983;99:341-2
5. Bober SA, McGill AC, Tunbndge WMG. Thyroid function in hyperemesis gravidarum. Acts Endocrinol 1986;111:404-10.
6. Brabant A, Brabant G, Schuermeyer T, et al. The role of glucocorticoids in the regulation of thyrotropin. Acta Endocrinol 1989;121:95- 100.
7. Brabant G, Prank K, Hoang-Vu C, et al. Hypothalarnic regulation of pulsatile thyrotropin secretion. J Clin Endocrinol Metab 1991,72:145-50.
8. Brent GA, Hershman JM. Thyroxine therapy in patients with severe nonthyroidal illnesses and low serum thyroxine concentrations. J Clin Endocrinol Metab 1986;63:1-8.
9. Burger A. Nondeiodinative pathways of thyroid hormone metabolism. In: Hennemann G, ed. Thyroid hormone metabolism, Vol 8. New York - Basel: Marcel Dekker, 1986:255-76.
10. Chopra IJ, Williams DE, Orgiazzi J, et al. Opposite effects of dexamethasone on serum concentrations of 3,3′5′-triiodothyronine (reverse T3) and 3,3′5-triiodothyronine (T3). J Clin Endocrinol Metab 1975,41:911-20.
11. Chopra IJ, Solomon DH, Chua Teco GN, et al. An inhibitor of the binding of thyroid hormones to serum proteins is present in extrathyroidal tissues. Science 1982,215:407-9.
12. Chopra IJ, Santini F, Hurd RE, et al A radioimmunoassay for measurement of thyroxine sulfate. J Clin Endocrinol Metab 1993,76.145-50
13. Chopra IJ, Hershman JM, Pardndge WM, et al Thyroid function in non thyroidal illnesses. Ann Intern Med 1983,98:946-57.
14. Chopra IJ, Wu SY, Chua Teco GN, et al. A radioimmunoassay for measurement it of 3.5.3′-triiodothyronine sulfate: studies in thyroidal and nonthyroidal diseases, pregnancy, and neonatal life. J Clin Endocrinol Metab 1992;75:189-94
15. Chopra IJ, Huang TS, Solomon DH, et al. The role of thyroxine (T4)-binding serum proteins in oleic acid-induced increase in free T4 in nonthyroidal illnesses. J Clin Endrocrinol Metab 1986;63 776-9
16. Cooper DS, Klibanski A, Ridgway EC. Dopaminergic modulation of TSH and its subunits: in vivo and in vitro studies. Clin Endocrinol (Oxf) 1983;18:265-75
17. Csako G, Zweig NJ, GlickmanJ, et al. Direct and indirect techniques for free thyroxine compared in patients with nonthyroidal illness. II. Effect of prealbumin, albumin and thyroxin-binding globulin. Clin Chem 1989;35: 1655-62.
18. Custro N, Scafidi V, Notarbartolo A. Alterations in circadian rhythm of serum thyrotropin in critically ill patients. Acta Endocrinol 1992;127 18-22.
19. Danforth E Jr. Effects of fasting and altered nutrition on thyroid hormone metabolism in man. In: Hennemann G, ed. Thyroid hormone Metabolism, Vol 8. New York - Basel: Marcel Dekker, 1986:335-51
20. Davies PH, Black EG, Sheppard MC, et al. Relation between serum interleukin-6 and thyroid hormone concentrations in 270 hospital in-patients with non-thyroidal illness Clin Endocrinol 1996;44:199-205.
21. De Groot LJ, Hoye K Dexamethasone suppression of serum T3 and T4. J Clin Endocrinol Metab 1976;42 976-8.
22. De Groot LJ Abnormal thyroid function tests in euthyroid patients In: Hamburger JI, ed Diagnostic methods in clinical thyroidology. Berlin - Heidelberg - New York: Springer, 1989
23. Docter R, Krenning EP, de Jong M, et al. The sick euthyroid syndrome, changes in thyroid hormone serum parameters and hormone metabolism. Clin Endocrinol 1993,39:499-518
24. Engler D, Burger AG. The deiodination of the iodothyronines and their derivatives in man. Endocrinol Rev 1984;5 151-84.
25. Evans RD, Argiles JM, Williamson DH. Metabolic effects of tumor necrosis factor-alpha (cachectin) and interleukin-1. Clin Sci 1989;77:357-64.
26. Everts ME, de Jong M, Lim C-F, et al. Different regulation of thyroid hormone transport in liver and pituitary: its possible role in the maintenance of low T3 production during nonthyroidal illness and fasting in man. Thyroid 1996,6:359-69.
27. Faber J, Kirkegaard C, Rasmussen B, et al Pituitary-thyroid axis in critical illness. J Clin Endocrinol Metab 1987,65:315-20.
28. Faber J. Waetjen I, Siersbaek-Nielsen K. Free thyroxine measured in undiluted serum by dialysis and ultrafiltration: effects of non-thyroidal illness, and an acute load of salicylate or heparin. Clin Chim Acta 1993;223:159-67.
29. Gärtner R, Angstwurm MW, SchottdorfJ. Selensubstitution bei Sepsispatienten Med Klin 1997,92:Suppl 3:12-4
30. Hamblin PS, Dyer SA, Mohr VS, et al. Relationship between thyrotropin and thyroxine changes during recovery from severe hypothyroxinemia of critical illness. J Clin Endocrinol Metab 1986;62:717-22.
31. Haynes IG, Lockert SJ, Farmer MJ, et al. Is oleic acid the thyroxine binding inhibitor in the serum of ill patients? Clin Endocrinol 1989;31.25-30.
32. Hein MD, Jackson IMD. Review thyroid function in psychiatric illness Gen Hosp Psychiat 1990;12:232-44.
33. Heinen E, Herrmann J, Koninghausen TH, et al. Secondary hypothyroidism in severe non thyroidal illness. Horin Metab Res 1981;13:284-8.
34. Hesch RD, Hüsch M, Kodding R, et al. Treatment of dopamine-dependent shock with triiodothyronine. Endocr Res Commun 1981;8:229-37.
35. Hollander CS, Scott RL, Burgess JA, et al Free fatty acids: a possible regulator of free thyroid hormone levels in man. J Clin Endocrinol Metab 1967;27:1219-23.
36. Hüfner M. Probleme bei der Bewertung von Schilddrüsenfunktionsparametern bei schwerkranken Patienten. Dtsch Med Wochenschr 1984;109:1981.
37. Isojarvi JIT, Pakarinen AJ, Myllyia VV. Thyroid function in epileptic patients treated with carbamazepine. Arch Neurol 1989;46:1175-8.
38. Kaptein EM. Thyroid hormone metabolism and thyroid disease in chronic renal failure Endocrinol Rev 1996,17:45-63
39. Kaptein EM, Spencer CA, Kamiel MB, et al. Prolonged dopamine administration and thyroid hormone economy in normal and critically ill subjects. J Clin Endocrinol Metab 1980,51:387-93.
40. Kaptein EM, Grieb DA, Spencer CA, et al. Thyroxine metabolism in the low thyroxine state of critical nonthyroidal illnesses. J Clin Endocrinol Metab 1981;53:764
41. Kaptein EM, Weiner JM, Robinson WJ, et al. Relationship of altered thyroid hormone indices to survival in nonthyroidal illnesses Clin Endocrinol 1982;16:565-74.
42. Kaptein EM, Kletzky OA, Spencer CA, et al. Effect of prolonged dopamine infusion on anterior pituitary function in normal males. J Clin Endocrinol Metab 1980;51:488-9.
43. Kaptein EM Thyroid hormone metabolism in illness In. Hennemann G, ed. Thyroid hormone metabolism, Vol 8. New York - Basel Marcel Dekker, 1986:297-333
44. Kehlet H, Klauber PV, WeekeJ Thyrotropin, free and total triiodothvronine, and thyroxine in serum during surgery. Clin Endocrinol 1979,10:131-6.
45. Kew MC. Thyroxine binding globulin, hyperthyroxinemia and hepatocellular carcinoma. Hepatology 1991,13 808-9.
46. Klemperer JD, Klein I, Gomez M, et al. Thyroid hormone treatment after coronary-artery bypass surgery. N Engl J Med 1995;333:1522-7.
47. Lee H-Y, Suhl J, Pekary AE, et al. Secretion of thyrotropin with reduced concanavalin-A-binding activity in patients with severe nonthyroid llness. J Clin Endocrinol Metab 1987;65:942.
48. LoPresti JS, Gray D, NicolorfJT Influence of fasting and refeeding on 3,5′,5′-triiodothyronine metabolism in man. J Clin Endocrinol Metab 1991;72:130-6
49. LoPresn JS, Fried JC, Spencer CA, et al. Unique alterations of thyroid hormone indices in the acquired immunodeficiency syndrome (AIDS), Ann Intern Med 1989;110:970-5.
50. Martino E, Safran M, Aghini-Lombardi F, et al Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy Ann Intern Med 1984,161 28-34.
51. Melmed S, Geola FL, Reed AW, et al. A comparison of methods for assessing thyroid function in nonthyroidal illness. J Clin Endocrinol Metab 1982;54:300-6
52. Mendel CM, Frost PH, Kunitake ST, et al. Mechanism of the heparin-induced increase in the concentration of free thyroxine in plasma J Clin Endocrinol Metab 1987;65:1259-64.
53. Mooradian AD, Reed RL, Osrterweil D, et al. Decreased serum triiodothyronine is associated with increased concentrations of tumor necrosis factor. J Clin Endocrinol Merab 1990,71.1239-42.
54. NicoloffJT Alternate pathways of thyroid hormone metabolism. In: Wu Sy. Thyroid hormone metabolism. Oxford - Edinburgh: Blackwell Scientific, 1991:55-64
55. Nomura S, Pittman CS, Chambers JB Jr, et al. Reduced peripheral conversion of thyroxine to triiodothyronine in patients with hepatic cirrhosis. J Clin Invest 1975,56 643-9.
56. Ozawa M, Sato K, Han DC, et al Effects of tumor necrosis factor a/cachectin on thyroid hormone metabolism in mice Endocrinology 1988;123:1461-7
57. Pernld H, Hansen JM, Skovsted L, et al. Different effects of propranolol, alprenolol, sotalol, atenolol and metoprolol on serum T3 and serum rT3 in hyperthyroidism. Clin Endocrinol (Oxf) 1983;18:139-42.
58. Prescott RWG, Yeo PPB, Watson MJ, et al. Total and free thyroid hormone concentrations after elective surgery. J Clin Pathol 1979;32:321-4.
59. Re RN, Kourides IA, Ridgway EC, et al The effect of glucocorticoid administration on human pituitary secretion of thyratropin and prolactin J Clin Endocrinol Metab 1976;43.338-46.
60. Reinhardt W, Misch C, Jockenhövel F, et al. Triiodothyronine reflects renal graft function after renal transplantation Clin Endocrinol (Oxf) 1997,46:565-9
61. Reinhardt W. Holtermann D, Benker G, et al. Effect of small doses of iodine on thyroid function during caloric restriction in normal subjects. Horm Res 1993;39:132-7
62. Reinhardt W. Mocker V, Jockenhovel F. et al. The influence of coronary artery bypass surgery on thyroid hormone function Horm Res 1997:47:1-8
63. Roca RP, Blackman MR, Ackerley MB, et al. Thyroid hormone elevations during acute psychiatric illness: relationship to seventy and distinction from hyperthyroidism. Endocrinol Res 1990;16:415-47
64. Romijn JA, Wiersinga WM. Decreased nocturnal surge of thyrotropin in nonthyroidal illness. J Clin Endocrinol Metab 1990;.35-42.
65. Roti E, Minelli R, Gardini E, et. al. Iodine indured subclinical hypothyroidism in euthyroid subjects with a previous episode of amiodarone-induced thyrotoxicosis J Clin Endocrinol Metab 1992;75:1273-7.
66. Saller B. Hyperthyreose bei Trophoblastentumoren In: Reinwein D, Weinheimer B, Hrsg. Schilddrüse Berlin: de Gruyter, 1993.314-22
67. Santini F, Chiovato L, Bartalena L, et al. A study of serum 3.5 3′-triiodothyronnine sulfate concentration in patients with systemic non-thyroidal illness. Eur J Endocrinol 1996;134 4-50
68. Schifferdecker E, Hering S, Bohm BO, et al. Thyroid hormone binding inhibition in critically ill patients - Who is the inhibitor? Exp Clin Endocrinol 1990,95:267-70.
69. Slag MF, Morley JE, Elson MK, et al Hypothyroxinaemia in critically ill patients as a predictor of high mortality JAMA 1981;245 43-5.
70. Spaulding SW, Smith TJ, Hinkle PM, et al. Studies on the biological activity of triiodothyronine sulfate. J Clin Endocrinol Metab 1992;74:1062-7.
71. Spencer CA. Lo Presti LJS, Patel A, et al. Applications of a new chemiluminometric thyrotropin assay to subnormal measurement J Clin Endocrinol Metab 1990;70.453-60
72. Spencer CA, Eigen A, Shen D, et al Specifity of sensitive assavs of thyrotropin (TSH) used 10 screen for thyroid disease in hospitalized parients. Clin Chem 1991;33 1391-6
73. Stockigt JR, Topliss DJ Assessment of thyroid fonction during high-dose furosemide therapy Arch Intern Med 1989;149 973
74. Trip MD. Wiersinga W, Plomp TA Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism Am J Med 1991;91:507-10.
75. van der Poll T. Rornijn JA, Wiersinga WM, et al. Tumor necrosis factor: a putative mediator of the sick euthyroid syndrome in man. J Clin Endocrinol Metab 1990;71:1567-72.
76. Visser TJ. Role of sulfation in thyroid hormone metabolism. Chem Biol Interact 1994;92 293-303.
77. Wartofsky L, Burman KD. Alterationsin thyroid function in patients with systemic illnesses: The "euthyroid sick syndrome". Endocrinol Rev 1982;3:164-217.
78. Watters JM, Wilmore DW. The metabolic responses to trauma and sepsis. In: De Groot LJ, ed Endocrinology, 2nd ed. Philadelphia: Saunders, 19xx:2367-93
79. Wehrnann RE, Gregerman RJ, Burns WH, et al. Suppression of thyrotropin in the low-thyroxine state of severe nonthyroidal illness. N Engl J Med 1985, 312:546-52.
80. Wenzel KW. Thyroxine analogue assay kits in clinical medicine. Lancet 1985;2:781-2
81. Wiersinga WM, Lie KI, TouberJL Thyroid hormones in acute myocardial infarction Clin Endocrinol 1981;14:367-74.
82. Wolfson MS, Raouf AA, O'Gorman P, et al. Rapid adaptation of pituitary responsiveness to TRH in the post-surgical state. The role of free T3. Clin Endocrinol 1981;15 579-84
83. Zimrnermann T, Albrecht S, Nagel M, et al. Low T3-syndrome in septic patients, phenomenon or important pathogenetic factor? Exp Clin Endocrinol 1996;104:Suppl 1.